Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical intranasal estrogen for non-allergic rhinitis in postmenopausal women
IRCT20200926048841N2Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of conjugated estrogens in non-allergic rhinitis (NAR) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Improvement in nasal airflow. Started May 2022; status: completed.
02
Drugs
conjugated estrogens
03
Conditions
non-allergic rhinitis (NAR)
Beyond the preview
Go deeper on IRCT20200926048841N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200926048841N2.